New developments in alpha 1-antitrypsin deficiency

被引:7
|
作者
Aboussouan, LS
Stoller, JK
机构
[1] Wayne State Univ, Sch Med, Div Pulm & Crit Care Med, Harper Hosp, Detroit, MI 48201 USA
[2] Cleveland Clin Fdn, Dept Pulm & Crit Care Med, Cleveland, OH 44195 USA
关键词
alpha 1-antitrypsin deficiency; augmentation therapy; loop-sheet polymerization; lung physiopathology; lung transplantation; lung volume reduction;
D O I
10.1055/s-2007-1021327
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Alpha 1-antitrypsin deficiency is an autosomal codominant condition associated with the development of premature emphysema, chronic liver disease, diseases of arterial vascular tissue such as aneurysm formation, and possibly vasculitis. Whereas unchecked proteolytic activity of neutrophil elastase is the likely etiology of premature emphysema and diseases of arterial vascular tissue, chronic liver disease has only recently been proposed to be due to loop-sheet polymerization of the most common deficiency variant of the alpha 1-antitrypsin molecule, the PI*ZZ mutant. Recent evidence suggests that this disorder is underrecognized by health care providers with only 4% of the estimated 60,000 to 100,000 Americans having been identified. Intravenous augmentation therapy with purified pooled plasma derived alpha 1-antitrypsin has been shown to have biochemical efficacy in raising serum and alveolar lining fluid levels to above protective thresholds. Although uncontrolled studies suggest additional clinical efficacy, no randomized clinical trials of intravenous augmentation therapy have been reported to date. The use of gene therapy is currently limited by difficulties in obtaining sustained and therapeutic levels of alpha 1-antitrypsin expression. Alpha 1-antitrypsin deficiency accounts for 11% of all lung transplants performed, with post-transplantation survival rates of 45% at 5 years matching those of lung transplantation for chronic obstructive pulmonary disease in general. These recent advances raise further challenges such as the role of population screening, the prospects of newer therapies such as inhaled augmentation and gene therapy, and the feasibility of randomized placebo-controlled clinical trials.
引用
收藏
页码:301 / 310
页数:10
相关论文
共 50 条
  • [41] α1-Antitrypsin deficiency in childhood
    Teckman, Jeffrey H.
    SEMINARS IN LIVER DISEASE, 2007, 27 (03) : 274 - 281
  • [42] HEREDITARY ALPHA 1-ANTITRYPSIN DEFICIENCY AND INFANTILE CIRRHOSIS OF THE LIVER
    KAZDA, S
    MULLER, W
    BOHME, A
    CLEVE, H
    SCHONITZER, D
    REISSIGL, H
    WEISER, G
    PADIATRIE UND PADOLOGIE, 1982, 17 (04): : 695 - 704
  • [43] ALPHA 1-ANTITRYPSIN DEFICIENCY AND CHILDHOOD LIVER-DISEASE
    BURKE, JA
    BLAIR, JD
    KIESEL, JL
    GASTROENTEROLOGY, 1974, 66 (04) : 669 - 669
  • [44] Exacerbations in α1-antitrypsin deficiency
    Needham, M
    Stockley, RA
    EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (06) : 992 - 1000
  • [45] A Review of α1-Antitrypsin Deficiency
    Stoller, James K.
    Aboussouan, Loutfi S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (03) : 246 - 259
  • [46] α1-antitrypsin deficiency panniculitis
    McBean, J
    Sable, A
    Maude, J
    Bostom, LR
    CUTIS, 2003, 71 (03): : 205 - 209
  • [47] COPD New Lessons From α1-Antitrypsin Deficiency?
    Wanner, Adam
    CHEST, 2009, 135 (05) : 1342 - 1344
  • [48] α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency
    Bazzan, Erica
    Tine, Mariaenrica
    Biondini, Davide
    Benetti, Riccardo
    Baraldo, Simonetta
    Turato, Graziella
    Fagiuoli, Stefano
    Sonzogni, Aurelio
    Rigobello, Chiara
    Rea, Federico
    Calabrese, Fiorella
    Foschino-Barbaro, Maria Pia
    Miranda, Elena
    Lomas, David A.
    Saetta, Marina
    Cosio, Manuel G.
    CHEST, 2018, 154 (03) : 607 - 616
  • [49] Compelling evidence for the efficacy of α1-antitrypsin augmentation treatment for α1-antitrypsin deficiency
    Crystal, Ronald G.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 7 - 8
  • [50] Enigma of α1-antitrypsin:: α1-antitrypsin deficiency reveals a puzzling physiological function
    Nukiwa, T
    INTERNAL MEDICINE, 2001, 40 (04) : 271 - 272